Michele Di Lorenzo

Dr. Michele Di Lorenzo

Medicine, Surgery & Neuroscience, University of Siena, Siena, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in Lung
Verified
Journal Article
Closed access
PDF file
TPTommaso PIANIGIANI
Tommaso PIANIGIANI
PCPaolo Cameli
Paolo Cameli
MLMichele Di Lorenzo
Michele Di Lorenzo
LBLaura Bergantini
Laura Bergantini
EBElena Bargagli
Elena Bargagli

12 September 2025 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
SGSara Giovani
Sara Giovani
ABAdelaide Ballerini
Adelaide Ballerini
AGAlessia Gozzini
Alessia Gozzini
MLMichele Di Lorenzo
Michele Di Lorenzo
DMDavide Mei
Davide Mei
FGFrancesca Girolami
Francesca Girolami
This study investigates the genetic background of pediatric-onset cardiac channelopathies, a rare group of genetic disorders causing arrhythmias and sometimes sudden death, whose genetic background remains partially unknown. The research analyzed 59 pediatric patients (<18 years of age) diagnosed with different channelopathies (LQTS, BrS, CPVT, SQTS, and conduction disorders), along with 40 of their family members, using Next-Generation Sequencing (NGS) after genetic counseling. A causative genetic variant was found in 47% of cases, mainly in the KCNQ1 (42%), RYR2 (16%), CACNA1C (10%), and SCN5A (10%) genes. Notably, a de novo large deletion in KCNH2 was detected in an LQTS patient, and a pathogenic CALM1 variant was identified in a child. A compound heterozygous KCNQ1 was consistent with Jervell and Lange-Nielsen syndrome. In light of these data, genetic testing is crucial for diagnosis, prognosis, and treatment planning; cascade screening allowed early risk identification and preventive interventions for family members. Expanding NGS technologies and research on new candidate genes may enhance personalized therapies in the future.